Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Combined Detection of Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Patients With Narcolepsy

NCT04940806 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT04940806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04940806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Combined Detection of Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Patients With Narcolepsy
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2021
Completion date
June 30, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy